Calibrate your expectations to receive the 4Q11 and 2011 OnBioVC Trend Analysis in January. Thanks to many of our dedicated readers who have checked in with us during a quiescent period in the late fall. Some interesting plans are in the works – based upon your feedback on the recent survey – more details to follow.

Please bare with us as we play ‘catch-up’ over the next couple of weeks by posting deals that occurred over the last few months, thereby enabling the OnBioVC dBase to be as comprehensive and as accurate as possible.

Finally, you may find this article by our friend and Business Editor at Nature Biotechnology, Brady Huggett, “New Startup Models Emerge as Investor Landscape Shifts” to be both interesting and insightful, and of course we are very appreciative for the OnBioVC shoutout.